La dengue: de la maladie à la vaccination = DENGUE FEVER: FROM DISEASE TO VACCINATIONTEYSSOU, R.Médecine tropicale. 2009, Vol 69, Num 4, pp 333-334, issn 0025-682X, 2 p.Conference Paper

Prévention et dépistage du cancer du col utérin : ACTUALITÉS SUR LA PRÉVENTION = Prevention and screening of cervical cancerCARBILLON, L.La Lettre du cancérologue (Boulogne). 2014, Vol 23, Num 6, pp 214-217, issn 1165-113X, 4 p.Article

The Australian Experience With the Human Papillomavirus VaccineGARLAND, Suzanne M.Clinical therapeutics. 2014, Vol 36, Num 1, pp 17-23, issn 0149-2918, 7 p.Article

Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipientsPARKKALI, T; KÄYHTY, H; LEHTONEN, H et al.Bone marrow transplantation (Basingstoke). 2001, Vol 27, Num 1, pp 79-84, issn 0268-3369Article

Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)CROXTALL, Jamie D; DHILLON, Sohita.Drugs (Basel). 2012, Vol 72, Num 18, pp 2407-2430, issn 0012-6667, 24 p.Article

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoidDAGAN, R; MUALLEM, M; MELAMED, R et al.The Pediatric infectious disease journal. 1997, Vol 16, Num 11, pp 1060-1064, issn 0891-3668Article

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccinesPACE, David; POLLARD, Andrew J.Archives of disease in childhood. 2007, Vol 92, Num 10, pp 909-915, issn 0003-9888, 7 p.Article

Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigensDAGAN, R; MELAMED, R; ZAMIR, O et al.The Pediatric infectious disease journal. 1997, Vol 16, Num 11, pp 1053-1059, issn 0891-3668Article

Inactivated Quadrivalent Split-Virus Seasonal Influenza Vaccine (Fluarix^® Quadrivalent): A Review of Its Use in the Prevention of Disease Caused by Influenza A and BMCKEAGE, Kate.Drugs (Basel). 2013, Vol 73, Num 14, pp 1587-1594, issn 0012-6667, 8 p.Article

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US childrenBERNSTEIN, D. I; GLASS, R. I; RODGERS, G et al.JAMA, the journal of the American Medical Association. 1995, Vol 273, Num 15, pp 1191-1196, issn 0098-7484Article

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisJOENSUU, J; KOSKENNIEMI, E; PANG, X.-L et al.Lancet (British edition). 1997, Vol 350, Num 9086, pp 1205-1209, issn 0140-6736Article